News Focus
News Focus
icon url

frrol

12/05/14 10:41 AM

#80311 RE: BioHedge #80302

I don't think so... my opinion of Cellceutix is that its stock is undervalued but that doesn't mean I think the market is wrong per se. In other words, I recognize that I am taking risk. So I can disagree with the market but I don't feel that my view is "fringe". My view is "risky", and I accept that it may be wrong. I hope everyone on this board recognizes that CTIX is risky. It is not going to go straight up, the company should not be worth $10B right now, it has not cured most cancers, its drugs have not been approved for use, etc.

And I think this marks a good economist, since it is all theory as you point out. "Fringe" folks tend to be people who have 'figured it all out' and are utterly convinced they are right, and some malign group or mass of fools is preventing 'the truth'.
icon url

F1ash

12/05/14 10:45 AM

#80314 RE: BioHedge #80302

Thanks for your input on this board. I always look forward to reading your posts. I think the lack of recognition for the significance of Brilacidin's potential may be attributable to human psychology. The following is what I believe the investment community's view of CTIX is currently. Now try and convince them that we can win three superbowls and be married to a supermodel. We just need some game film to show them what they are missing.






icon url

scgmck1

12/05/14 12:00 PM

#80326 RE: BioHedge #80302

BH, do you know what you get when you put 10 economists in a room?
You get 10 different theories. Whichever way it goes, CTIX will be a winner next year and beyond; of that I'm certain.